Surgery Partners (SGRY) Long-Term Deferred Tax (2015 - 2024)

Surgery Partners has reported Long-Term Deferred Tax for 10 years, with the latest figure at $79.2 million in Q3 2024.

• Quarterly Long-Term Deferred Tax fell 24.57% year-over-year to $79.2 million in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $79.2 million (down 24.57% YoY) and the FY2023 annual result came in at $89.5 million, down 2.19% from the prior year.
• Long-Term Deferred Tax retreated to $79.2 million in Q3 2024 per SGRY's latest filing, from $81.8 million in the prior quarter.
• Over five years, Long-Term Deferred Tax peaked at $129.8 million in Q2 2021 and troughed at $79.2 million in Q3 2024.
• A 5-year average of $106.3 million and a median of $105.7 million in 2023 frame the typical range for Long-Term Deferred Tax.
• The sharpest annual moves came in 2020 and 2024: Long-Term Deferred Tax rose 26.44% in 2020, then declined 24.57% in 2024.
• Over 5 years, Long-Term Deferred Tax stood at $124.8 million in 2020, then fell by 8.33% to $114.4 million in 2021, then declined by 20.02% to $91.5 million in 2022, then decreased by 2.19% to $89.5 million in 2023, then dropped by 11.51% to $79.2 million in 2024.
• According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $79.2 million, $81.8 million, and $87.0 million for Q3 2024, Q2 2024, and Q1 2024 respectively.